Cibus Global LLC

NASDAQ:CBUS USA Biotechnology
Market Cap
$243.03 Million
Market Cap Rank
#16806 Global
#6437 in USA
Share Price
$3.68
Change (1 day)
+3.37%
52-Week Range
$1.16 - $4.05
All Time High
$1574.00
About

Cibus, Inc., an agricultural biotechnology company, develops and licenses gene edited plant traits using gene editing technologies to enhance farming productivity or produce renewable low carbon plant products. It focuses on trait productivity in the productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable i… Read more

Cibus Global LLC (CBUS) - Total Assets

Latest total assets as of September 2025: $330.23 Million USD

Based on the latest financial reports, Cibus Global LLC (CBUS) holds total assets worth $330.23 Million USD as of September 2025.

Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Cibus Global LLC - Total Assets Trend (2015–2024)

This chart illustrates how Cibus Global LLC’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.

Cibus Global LLC - Asset Composition Analysis

Current Asset Composition (December 2024)

Cibus Global LLC's total assets of $330.23 Million consist of 4.8% current assets and 95.2% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 4.1%
Accounts Receivable $1.04 Million 0.3%
Inventory $0.00 0.0%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $33.58 Million 9.6%
Goodwill $253.47 Million 72.4%

Asset Composition Trend (2015–2024)

This chart illustrates how Cibus Global LLC's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Cibus Global LLC's current assets represent 4.8% of total assets in 2024, a decrease from 96.3% in 2015.
  • Cash Position: Cash and equivalents constituted 4.1% of total assets in 2024, down from 95.0% in 2015.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 81.0% of total assets, an increase from 0.0% in 2015.
  • Asset Diversification: The largest asset category is goodwill at 72.4% of total assets.

Cibus Global LLC Competitors by Total Assets

Key competitors of Cibus Global LLC based on total assets are shown below.

Company Country Total Assets
MedPacto Inc
KQ:235980
Korea ₩51.58 Billion
2H0
F:2H0
Germany €15.27 Million
Shenzhen CAU Technology Co Ltd
SHE:000004
China CN¥260.55 Million
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
China CN¥9.58 Billion
Nanhua Bio Medicine Co Ltd
SHE:000504
China CN¥841.96 Million
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
China CN¥509.14 Million
Chengzhi Shareholding Co Ltd
SHE:000990
China CN¥27.52 Billion
Hualan Biological EngineeringInc
SHE:002007
China CN¥16.27 Billion

Cibus Global LLC - Asset Efficiency Metrics

Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.

Asset Turnover Ratio

Measures how efficiently a company uses its assets to generate sales

Historical Range: 0.00 - 0.70

Lower asset utilization - Cibus Global LLC generates 0.01x its asset value in annual revenue.

Return on Assets (ROA)

Measures how efficiently a company uses its assets to generate profits

Historical Range: -78.50% - -22.65%

Negative ROA - Cibus Global LLC is currently not profitable relative to its asset base.

Cibus Global LLC - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.28 1.44 5.70
Quick Ratio 1.28 1.44 5.50
Cash Ratio 0.00 0.00 0.00
Working Capital $5.68 Million $ 9.65 Million $ 32.65 Million

Cibus Global LLC - Advanced Valuation Insights

This section examines the relationship between Cibus Global LLC's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 5.20
Latest Market Cap to Assets Ratio 0.40
Asset Growth Rate (YoY) -35.7%
Total Assets $350.07 Million
Market Capitalization $138.92 Million USD

Valuation Analysis

Below Book Valuation: The market values Cibus Global LLC's assets below their book value (0.40 x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Cibus Global LLC's assets decreased by 35.7% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Cibus Global LLC (2015–2024)

The table below shows the annual total assets of Cibus Global LLC from 2015 to 2024.

Year Total Assets Change
2024-12-31 $350.07 Million -35.70%
2023-12-31 $544.41 Million +2328.13%
2022-12-31 $22.42 Million -39.72%
2021-12-31 $37.19 Million -41.27%
2020-12-31 $63.33 Million -28.12%
2019-12-31 $88.10 Million -25.84%
2018-12-31 $118.79 Million +64.61%
2017-12-31 $72.17 Million +334.14%
2016-12-31 $16.62 Million -36.05%
2015-12-31 $26.00 Million --